A detailed history of Bollard Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bollard Group LLC holds 2,262 shares of ABBV stock, worth $400,260. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,262
Previous 2,260 0.09%
Holding current value
$400,260
Previous $388,000 15.21%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.09%
2,262 $447,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $210,978 - $246,375
-1,363 Reduced 37.62%
2,260 $388,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $38,836 - $44,250
-243 Reduced 6.29%
3,623 $660,000
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $99,347 - $111,888
-722 Reduced 15.74%
3,866 $599,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $3,339 - $3,866
25 Added 0.55%
4,588 $684,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $20,009 - $24,899
151 Added 3.42%
4,563 $615,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $3,326 - $3,830
23 Added 0.52%
4,412 $703,000
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $3,181 - $3,815
23 Added 0.53%
4,389 $709,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $3,221 - $3,694
24 Added 0.55%
4,366 $586,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $3,027 - $3,849
22 Added 0.51%
4,342 $665,000
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $3,167 - $3,930
24 Added 0.56%
4,320 $700,000
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $2,793 - $3,534
26 Added 0.61%
4,296 $582,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $2,766 - $3,140
26 Added 0.61%
4,270 $461,000
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $2,630 - $2,930
25 Added 0.59%
4,244 $478,000
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $2,864 - $3,153
28 Added 0.67%
4,219 $457,000
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $2,173 - $2,934
27 Added 0.65%
4,191 $449,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $2,405 - $2,823
28 Added 0.68%
4,164 $365,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $2,054 - $2,749
28 Added 0.68%
4,136 $406,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $1,677 - $2,542
26 Added 0.64%
4,108 $313,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $1,947 - $2,436
27 Added 0.67%
4,082 $361,000
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $2,141 - $2,574
34 Added 0.85%
4,055 $307,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $1,839 - $2,351
28 Added 0.7%
4,021 $292,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $2,082 - $2,451
27 Added 0.68%
3,993 $322,000
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $9,419 - $11,617
121 Added 3.15%
3,966 $366,000
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $1,778 - $1,976
20 Added 0.52%
3,845 $364,000
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $1,616 - $1,912
18 Added 0.47%
3,825 $354,000
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $1,196 - $1,601
13 Added 0.34%
3,807 $360,000
Q4 2017

Jan 29, 2018

BUY
$89.56 - $98.21 $1,164 - $1,276
13 Added 0.34%
3,794 $367,000
Q3 2017

Oct 27, 2017

BUY
$69.85 - $89.22 $264,102 - $337,340
3,781
3,781 $336,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.